Brevetti EPO No.3810089 2023.08.02
Brevetti EPO
(10) Registration Number and Date
2023000307 2023.09.18
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2023/000307 2019.06.04
(40) Publication Number and Date
SM /T/2023/000307 2023.09.18
(30) Priority Details
US 201862681722 P
2018.06.07
US 201962796133 P
2019.01.24
US 201962841882 P
2019.05.02
US 201862754651 P
2018.11.02
(71/73) Applicant
(72) Inventor
(IT) BRIGHT, Andrew Gilbert : c/o Pfizer Limited Ramsgate Road, Sandwich Kent CT13 9NJ, GB
(IT) HUSSEY, James Joseph : c/o Pfizer Limited Ramsgate Road, Sandwich Kent CT13 9NJ, GB
(74) Representative Name
(IT) SANTI, Filippo : Via Consiglio dei Sessanta, 99, 47891 Dogana RSM, SM
(54) Title
(IT) FORMULAZIONE ACQUOSA CHE COMPRENDE 1-(4-{[4-(DIMETILAMMINO)PIPERIDIN-1-IL]CARBONIL}FENIL)-3-[4-(4,6-DIMORFOLIN-4-IL-1,3,5- TRIAZIN-2-IL)FENIL]UREA.
(EN) AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA
(57) Abstract
(58) Citations